Elotuzumab (anti-SLAMF7)
$80.87
*The price shown here is solely for reference purposes. For a formal quote, please contact us at sales@labsolu.ca
Purity: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated Synonym(s): Recombinant Elotuzumab Antibody; Elotuzumab; HuLuc 63; PDL 063; BMS 901608; Elotuzumab (anti-SLAMF7); BMS-901608; PDL063; HuLuc63; Empliciti; 19A antibody; 19A24 protein antibody; CD 319 antibody; CD2 like receptor activating cytotoxic cells antibody; CD2 subset 1 antibody; CD319 antibody; CD319 antigen antibody; CRACC antibody; CS1 antibody; Membrane protein FOAP 12 antibody; Novel Ly9 antibody; Novel LY9 (lymphocyte antigen 9) like protein antibody; Protein 19A antibody; SLAM family member 7 antibody; SLAMF 7 antibody; 19A; CD2 subset 1; CD2-like receptor activating cytotoxic cells; CD319 antigen; CD319; CRACC; CRACCCD2-like receptor-activating cytotoxic cells; CS119A24 protein; Membrane protein FOAP-12; Novel LY9 (lymphocyte antigen 9) like protein; Novel Ly9; Protein 19A; SLAM family member 7; SLAMF7 Formula: Molecular Weight: CAS Number: 915296-00-3 MDL Number:
Product description
Properties
Shelf life: 730 days
Solubility:
Sensitivity:
Boiling point:
Melting point:
InChl:
Safety Information
Pictograms:
Signal Word:
Hazard Statements:
Precautionary Statements:
WGK:
Storage: Store at -80°C; Avoid repeated freezing and thawing
Personal Protective Equipment:
Additional information
| Pack size | 100μg |
|---|
